|
Realtime
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 0.5560 EUR | -0.36% |
|
-10.03% | -63.80% |
| 13.07. | AB Science stellt drei klinische Studien zu Masitinib ein | MT |
| 10.07. | AB Science strafft sein Portfolio und konzentriert sich auf zwei Wirkstoffe |  |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.36% | -10.03% | -35.94% | -52.32% | -63.80% | -55.31% | -86.59% | -96.37% | -96.02% | 50.96 Mio. | |
| +0.96% | +3.12% | +10.38% | +12.92% | +21.10% | +56.19% | +15.47% | +66.56% | +116.71% | 315 Mrd. | |
| +0.18% | -0.76% | +1.41% | +22.18% | +11.66% | +21.91% | -13.11% | -21.30% | +41.21% | 67.93 Mrd. | |
| -0.99% | +2.64% | +12.80% | +13.77% | +15.63% | +35.25% | +81.44% | +83.24% | +742.21% | 9.23 Mrd. | |
| -1.26% | -1.95% | +3.59% | +10.36% | +2.65% | +2.83% | -4.98% | -30.55% | +34.61% | 8.43 Mrd. | |
| -1.03% | -1.79% | -10.18% | -25.80% | -38.36% | -24.11% | -10.07% | -38.06% | - | 4.07 Mrd. | |
| +0.38% | -9.58% | +3.69% | +37.45% | +30.03% | -5.58% | +22.13% | -34.73% | - | 3.77 Mrd. | |
| +0.86% | +1.01% | -4.36% | -26.18% | -37.54% | -43.84% | +10.01% | +32.14% | +70.03% | 3.54 Mrd. | |
| -1.94% | -1.66% | +5.53% | -6.66% | -5.55% | +43.68% | +53.35% | +71.88% | +123.20% | 2.72 Mrd. | |
| -2.81% | -6.33% | +9.07% | -14.50% | -16.62% | +5.13% | -9.94% | +45.29% | - | 2.13 Mrd. | |
| +2.66% | -6.39% | +18.24% | -4.09% | +1.81% | -18.43% | +36.47% | -29.33% | - | 1.95 Mrd. | |
| +0.57% | -3.63% | +5.93% | -10.25% | -13.27% | -21.58% | -17.67% | -10.61% | -43.08% | 1.73 Mrd. | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64 Mrd. | |
| -0.05% | -8.11% | -1.87% | -26.25% | -15.13% | -36.56% | -30.60% | - | - | 1.21 Mrd. | |
| +0.88% | +13.19% | +33.19% | +84.58% | +157.72% | +198.70% | +1’367.34% | +665.91% | - | 1.19 Mrd. | |
| -6.56% | -6.73% | -14.78% | -43.19% | -43.06% | +30.70% | +22.73% | +11.60% | +410.45% | 1.06 Mrd. | |
| +0.83% | -18.71% | +12.79% | +4.85% | +13.85% | -13.84% | +91.88% | +6.98% | - | 1.14 Mrd. | |
| +0.72% | +0.60% | +5.24% | -7.05% | -9.25% | +1.20% | +39.74% | +85.90% | +75.54% | 1.06 Mrd. | |
| -1.30% | -5.70% | +0.77% | -20.81% | -23.75% | -36.54% | -75.64% | -84.79% | - | 878 Mio. | |
| +0.83% | -3.97% | -1.22% | -13.57% | -12.95% | -43.46% | -11.36% | -48.62% | -65.38% | 869 Mio. | |
| Durchschnitt | -0.37% | -3.06% | +2.86% | -3.40% | -1.31% | +5.07% | +77.93% | +37.51% | +128.13% | 21.47 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.66% | +2.84% | +8.39% | +13.19% | +17.42% | +45.46% | +15.47% | +48.87% | +115.80% |
- Börse
- Aktien
- A1CXBG Aktie
- Sektor AB Science
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
